Impact of Clinical Pharmacy Services on Medication Cost and Hospitalization Rates in Hemodialysis Patients

Sponsor

University of New Mexico (Other)

Overall Status

Withdrawn

CT.gov ID

NCT05952388

Collaborator

(none)

Enrollment

Arm

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the effects of pharmaceutical care interventions in the ambulatory hemodialysis patients over a one-year period. Cost containment occurs through pharmaceutical care interventions designed to identify and ameliorate drug-related problems (DRPs), improve the cost-effectiveness of therapeutic regimens and prevent hospitalizations.

Condition or Disease	Intervention/Treatment	Phase
End Stage Renal Disease	Other: Behavioral Patient care	N/A

Detailed Description

Approximately 350,000 end-stage renal disease (ESRD) patients in the United States utilized over $17.9 billion Medicare dollars in 1999. The ESRD population and cost is projected to double by 2010. ESRD patients have a mean of 5 comorbidities per patient and are prescribed a median of eight medications. The average monthly medication cost per patient is approximately $1,200.00. For every dollar spent on medication an additional $1.77 is spent on drug-related problems (DRPs). Dialysis patients are at high risk for DRPs. It is unknown if continued pharmacist intervention in hemodialysis patients will improve patient care, reduce medication utilization and cost, and prevent hospitalization as seen in other populations. The purpose of this study is to investigate the impact of continued pharmacist intervention in ambulatory hemodialysis patients.

Study Design

Study Type:

Interventional

Actual Enrollment :

0 participants

Allocation:

Randomized

Intervention Model:

Parallel Assignment

Masking:

None (Open Label)

Primary Purpose:

Health Services Research

Official Title:

Impact of Clinical Pharmacy Services on Medication Cost and Hospitalization Rates in Hemodialysis Patients

Actual Study Start Date :

Jan 1, 2003

Actual Primary Completion Date :

Jan 1, 2003

Actual Study Completion Date :

Jan 1, 2003

Arms and Interventions

Arm	Intervention/Treatment
No Intervention: Behavioral Patient Care Chart review	Other: Behavioral Patient care chart review Other Names: Chart review

Arm

Intervention/Treatment

No Intervention: Behavioral Patient Care

Chart review

Other: Behavioral Patient care

chart review

Other Names:

Chart review

Outcome Measures

Primary Outcome Measures

Reduction in at home medications [through study completion, an average of 1 year]
Behavioral: Patent care

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Patients are eligible for inclusion in the study if they have been on HD for greater than three months, greater than 18 years of age, those who plan to be continuously enrollment in therapy at the same dialysis center throughout the duration of the study. Informed consent will be obtained on eligible patients. The study is to be approved by the Human Research Review Committee prior to initiation.

Exclusion Criteria:

Patients will be excluded if they have been on HD for less than three months, decline the opportunity to participate, or are less than 18 years of age.